Browse by Journal Title

2020

Value of neuropsychological tests to identify patients with depressive symptoms on the Alzheimer's disease continuum.
Menne, F. and Schipke, C.G. and Klostermann, A. and Fuentes-Casañ, M. and Freiesleben, S.D. and Bauer, C. and Peters, O.
Journal of Alzheimer's Disease 78 (2): 819-826. 10 November 2020

Plasma amyloid concentration in Alzheimer's disease: performance of a high-throughput amyloid assay in distinguishing Alzheimer's disease cases from controls.
Feinkohl, I. and Schipke, C.G. and Kruppa, J. and Menne, F. and Winterer, G. and Pischon, T. and Peters, O.
Journal of Alzheimer's Disease 74 (4): 1285-1294. 21 April 2020

2017

Antibodies to signaling molecules and receptors in Alzheimer's disease are associated with psychomotor slowing, depression, and poor visuospatial function.
Giil, L.M. and Vedeler, C.A. and Kristoffersen, E.K. and Nordrehaug, J.E. and Heidecke, H. and Dechend, R. and Schulze-Forster, K. and Muller, D.N. and von Goetze, V.S. and Cabral-Marques, O. and Riemekasten, G. and Vogelsang, P. and Nygaard, S. and Lund, A. and Aarsland, D.
Journal of Alzheimer's Disease 59 (3): 929-939. 29 July 2017

2015

The latent dementia phenotype δ is associated with cerebrospinal fluid biomarkers of Alzheimer's disease and predicts conversion to dementia in subjects with mild cognitive impairment.
Koppara, A. and Wolfsgruber, S. and Kleineidam, L. and Schmidtke, K. and Froelich, L. and Kurz, A. and Schulz, S. and Hampel, H. and Heuser, I. and Peters, O. and Reischies, F.M. and Jahn, H. and Luckhaus, C. and Huell, M. and Gertz, H.J. and Schroeder, J. and Pantel, J. and Rienhoff, O. and Ruether, E. and Henn, F. and Wiltfang, J. and Maier, W. and Jessen, F. and Kornhuber, J. and Wagner, M.
Journal of Alzheimer's Disease 49 (2): 547-560. 17 October 2015

Validation of the Erlangen score algorithm for the prediction of the development of dementia due to Alzheimer's disease in pre-dementia subjects.
Lewczuk, P. and Kornhuber, J. and Toledo, J.B. and Trojanowski, J.Q. and Knapik-Czajka, M. and Peters, O. and Wiltfang, J. and Shaw, L.M.
Journal of Alzheimer's Disease 48 (2): 433-441. 9 September 2015

Alzheimer amyloid Peptide aβ42 regulates gene expression of transcription and growth factors.
Barucker, C. and Sommer, A. and Beckmann, G. and Eravci, M. and Harmeier, A. and Schipke, C.G. and Brockschnieder, D. and Dyrks, T. and Althoff, V. and Fraser, P.E. and Hazrati, L.N. and St George-Hyslop, P. and Breitner, J.C.S. and Peters, O. and Multhaup, G.
Journal of Alzheimer's Disease 44 (2): 613-624. 1 January 2015

2013

APOE-dependent phenotypes in subjects with mild cognitive impairment converting to Alzheimer's disease.
Morgen, K. and Froelich, L. and Tost, H. and Plichta, M.M. and Koelsch, H. and Rakebrandt, F. and Rienhoff, O. and Jessen, F. and Peters, O. and Jahn, H. and Luckhaus, C. and Huell, M. and Gertz, H.J. and Schroeder, J. and Hampel, H. and Teipel, S.J. and Pantel, J. and Heuser, I. and Wiltfang, J. and Ruether, E. and Kornhuber, J. and Maier, W. and Meyer-Lindenberg, A.
Journal of Alzheimer's Disease 37 (2): 389-401. 3 July 2013

SorLA deficiency dissects amyloid pathology from tau and cholinergic neurodegeneration in a mouse model of Alzheimer's disease.
Capsoni, S. and Carlo, A.S. and Vignone, D. and Amato, G. and Criscuolo, C. and Willnow, T.E. and Cattaneo, A.
Journal of Alzheimer's Disease 33 (2): 357-371. 2013

2011

Association of N-acetylaspartate and cerebrospinal fluid Aβ42 in dementia.
Jessen, F. and Lewczuk, P. and Guer, O. and Block, W. and Ende, G. and Froelich, L. and Hammen, T. and Arlt, S. and Kornhuber, J. and Kucinski, T. and Popp, J. and Peters, O. and Maier, W. and Traeber, F. and Wiltfang, J.
Journal of Alzheimer's Disease 27 (2): 393-399. 2011

Long-term stability of Alzheimer's disease biomarker proteins in cerebrospinal fluid.
Schipke, C.G. and Jessen, F. and Teipel, S. and Luckhaus, C. and Wiltfang, J. and Esselmann, H. and Froelich, L. and Maier, W. and Ruether, E. and Heppner, F.L. and Prokop, S. and Heuser, I. and Peters, O.
Journal of Alzheimer's Disease 26 (2): 255-262. 2011

2009

Measurement of ERK 1/2 in CSF from patients with neuropsychiatric disorders and evidence for the presence of the activated form.
Klafki, H.W. and Lewczuk, P. and Kamrowski-Kruck, H. and Maler, J.M. and Mueller, K. and Peters, O. and Heuser, I. and Jessen, F. and Popp, J. and Froelich, L. and Wolf, S. and Prinz, B. and Luckhaus, C. and Schroeder, J. and Pantel, J. and Gertz, H.J. and Koelsch, H. and Mueller, B.W. and Esselmann, H. and Bibl, M. and Kornhuber, J. and Wiltfang, J.
Journal of Alzheimer's Disease 18 (3): 613-622. 2009

Astrocyte function is modified by Alzheimer's disease-like pathology in aged mice.
Peters, O. and Schipke, C.G. and Philipps, A. and Haas, B. and Pannasch, U. and Wang, L.P. and Benedetti, B. and Kingston, A.E. and Kettenmann, H.
Journal of Alzheimer's Disease 18 (1): 177-189. 2009